Chairman
GoodRx Holdings, Inc. (GDRX)Equibles does not estimate personal net worth.
Get an email with a short summary when GoodRx Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get GDRX alertsTrevor Bezdek is recorded as Chairman at GoodRx Holdings, Inc. (GDRX) since January 1, 2011. The newest filing on record that lists Trevor Bezdek as Chairman at GoodRx Holdings, Inc. (GDRX) is dated April 29, 2026. GoodRx Holdings, Inc. reported in an 8-K filed April 25, 2023 that Trevor Bezdek was appointed Chairman of the Board of Directors, effective April 25, 2023. The proxy statement of GoodRx Holdings, Inc. reports total compensation of $971,608 for Trevor Bezdek in fiscal 2025, including a base salary of $416,667. Disclosed compensation is on record for 7 fiscal years. Trevor Bezdek has spoken on 10 earnings calls across 1 company, most recently for GoodRx Holdings, Inc. on April 25, 2023. GoodRx Holdings, Inc. is classified in the Health Information Services industry within the Healthcare sector. Other leadership on record at GoodRx Holdings, Inc. includes Scott Wagner (CEO, Chairman and Board Member), Wendy Barnes (CEO and Board Member), Christopher A. McGinnis (CFO) and 7 others.
“The Corporation and the Executive mutually desire that the Executive continue to be employed by the Corporation as its Chairman, and to carry out the duties and responsibilities described below, all on the terms and conditions hereinafter set forth, and to replace and supersede the Prior Employment Agreement, in each case, effective as of the Effective Date (as defined below).”
“As Doug mentioned, we recognize the challenges both our business and our stock performance have faced over the past couple of years. We are still recovering from the impact the grocer issue we had on our core business.”
“Before getting into our fourth quarter results, I'm going to update you further on actions we've taken to strengthen our retail, pharmacy benefit manager and pharma manufacturer relationships.”
“Before getting into our third quarter results, I'm going to talk about the increasing strength of our retail, PBM and pharma manufacturer relationships as well as the health of our broader ecosystem.”
“As Doug said, we're disappointed by our year-to-date performance, and we're committed to driving towards higher growth and margin in the future.”
“Coming into 2022, we set four strategic priorities for the year: increasing consumer awareness and reach; strengthening our healthcare provider relationships; deepening our relationship with consumers; and finally, building or acquiring new platform capabilities that create the foundation for additional services and…”
2011-01-01–present
Last confirmed April 29, 2026
2011-01-01–2024-04-25
Last confirmed by a filing; no departure on record
Start not stated–2024-04-25
Last confirmed by a filing; no departure on record
Health Information Services · Healthcare
Chairman
2011-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | GoodRx Holdings, Inc. (GDRX) | Co-Chairman of the Board | $416,667 | $971,608 |
| 2024 | GoodRx Holdings, Inc. (GDRX) | Chairman of the Board | $500,000 | $853,918 |
| 2023 | GoodRx Holdings, Inc. (GDRX) | Chairman of the Board | $500,000 | $811,528 |
| 2022 | GoodRx Holdings, Inc. (GDRX) | Chairman of the Board | $500,000 | $537,005 |
| 2021 | GoodRx Holdings, Inc. (GDRX) | Chairman of the Board Former Co-Chief Executive Officer | $500,000 | $891,681 |
| 2020 | GoodRx Holdings, Inc. (GDRX) | Co-Chief Executive Officer | $500,000 | $267,652,442 |
| 2019 | GoodRx Holdings, Inc. (GDRX) | Co-Chief Executive Officer | $500,000 | $1,148,681 |
